Back to Search Start Over

Research on Sepsis Described by a Researcher at University of Wisconsin (116 Introduction of a Procalcitonin Screening Protocol in Severe Burn Patients: A Quality Improvement Initiative).

Source :
Drug Week; 5/10/2024, p378-378, 1p
Publication Year :
2024

Abstract

A report from the University of Wisconsin discusses research on sepsis in burn patients. Sepsis is a leading cause of mortality in critically ill burn patients, and current lab findings and signs can be non-specific for infection, leading to delays in treatment. The study explores the use of serum procalcitonin (PCT) as a biomarker for early diagnosis of sepsis in burn patients. The research found that PCT screening could be useful in aiding the detection of sepsis and reducing treatment delays in severe burn patients. Further refinement of the screening protocol is needed to determine testing frequency and useful cut-offs. [Extracted from the article]

Details

Language :
English
ISSN :
15316440
Database :
Complementary Index
Journal :
Drug Week
Publication Type :
Periodical
Accession number :
177005856